← All Sponsors
SPONSOR

IDEAYA Biosciences

Total Trials
2
Recruiting
2
Phases
Phase 1, Phase 1, Phase 2
Conditions studied: Advanced or Metastatic Solid TumorsBreast CancerOvarian CancerProstate CancerEndometrial CancerColorectal CancerHead and Neck CancersExtensive Stage Small Cell Lung Cancer (ES-SCLC)NSCLCSmall-cell Lung Cancer
NCT05787587 Phase 1
Recruiting

A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors

Advanced or Metastatic Solid Tumors
United States View Trial →
NCT07174583 Phase 1, Phase 2
Recruiting

A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer

Small-cell Lung Cancer
United States, Australia, Brazil View Trial →